A detailed history of Pinnacle Private Wealth, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Pinnacle Private Wealth, LLC holds 4,233 shares of MRNA stock, worth $161,912. This represents 0.24% of its overall portfolio holdings.

Number of Shares
4,233
Previous 4,539 6.74%
Holding current value
$161,912
Previous $782,000 22.63%
% of portfolio
0.24%
Previous 0.24%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 15, 2022

SELL
$117.13 - $176.59 $35,841 - $54,036
-306 Reduced 6.74%
4,233 $605,000
Q1 2022

Apr 29, 2022

BUY
$126.46 - $235.05 $158,201 - $294,047
1,251 Added 38.05%
4,539 $782,000
Q4 2021

Feb 07, 2022

BUY
$225.82 - $368.51 $742,496 - $1.21 Million
3,288 New
3,288 $835,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Pinnacle Private Wealth, LLC Portfolio

Follow Pinnacle Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Private Wealth, LLC with notifications on news.